Endocrine Abstracts

Background: The epidemic of obesity, together with its associated health burden, continues to spread globally. It is estimated that approximately 2.1 billion adults worldwide are now classified as overweight or obese. Thus, there is an urgent need to develop more effective strategies for preventing and managing obesity. Most population strategies to reduce the rising prevalence of non-communicable diseases (NCDs) have used a ‘one size fits all’ public health recommen...

Non-thyroidal illness syndrome is the alteration in thyroid function tests (TFTs) that occurs in critically ill patients, including those using thyrotoxic medications. Therefore, it is a challenge to interpret thyroid function tests in a critically ill patient on amiodarone. Case of 66-year-old male with history of heart failure with reduced ejection fraction, atrial fibrillation, and hypertension who presented to the emergency room due to progressive shortness of breath. Phys...

GH receptor stimulation changes intracellular protein phosphorylation and activates the JAK-STAT signalling pathway. The JAK2 - STAT5 components of this pathway seem critical for growth. Factors of essence for cellular effects of GH include the duration of GH receptor stimulation and in different species there are sex differences in GH secretion where males have an episodic and females have a more continuous mode of GH secretion. At the cellular level, these two types of GH se...

Background: Adipose tissue dysfunction occurring in obesity leads to a low grade chronic inflammatory state. Fat tissue from obese individuals has a high infiltration rate of macrophages contributing to the development of obesity-related inflammation. At the cellular level, inflammation can be triggered by the activation (phosphorylation) of NF-κB as well as JNK. On the other hand, palmitic acid (PA) is a saturated fatty acid found elevated in plasma from obese subjects a...

Background: Obesity is strongly associated with a state of chronic low grade systemic inflammation and insulin resistance (IR). IR at the molecular level may be defined as a diminished activation of the metabolic phosphatidylinositol-3-kinase (PI3K)/Akt pathway of insulin. On the other hand, inflammatory response may be activated by NF-κB. Subject with obesity have elevated plasma levels of saturated fatty acids, such as palmitic acid (PA), which triggers insulin and infl...

Introduction: There have been more than 130 genes described in relation with the development of obesity, which condition hyperphagia and early obesity. The aim of this study is to determine the prevalence of genetic alterations in a cohort of patients with morbid obesity.Materials and Methods: We designed a descriptive cross-sectional study for a cohort of subjects with obesity grade III or higher (BMI ≥40 kg/m2), treated at endocrinolog...

Introduction: Agonist receptor-GLP1 (AR-GLP1) had demonstrated its utility in obese patients with diabetes type 2. Since August 2013 we have available in Spain a new AR-GLP1 with prandial action in a single daily dose, lixisenatide. There are different clinical trials that support its efficacy and security but the dates from real clinical practice are scarce.Aim: To analyse the efficacy and security in real clinical practice for the treatment of diabetic...

Background and objectives: Evaluate the impact of therapy with GLP-1 analogues (liraglutide) on glycemic control and weight in patients with type 2 diabetes and poor metabolic control.Material and methods: We conducted a retrospective observational study analyzing 67 patients with type 2 diabetes mellitus and BMI >30 kg/m2, over 6 months of treatment. We evaluated HbA1c and weight at 3 and 6 months, performing statistical analysis with SPS...

Thyroid hormones (TH) are required for normal postnatal growth development in mammals. The physiological importance of TH becomes evident under the conditions of congenital–neonatal hypothyroidism (CH). If not treated immediately, CH has a profound impact on physiology and can permanently imprint neurological and endocrine systems, which, in turn, led to mental retardation, growth arrest, and metabolic disturbances. A delayed growth development or long-lasting influence o...

Introduction: The aim of this study was to evaluate effects on glycemic control, body weight and cardiovascular risk factors (BP, lipids and Epworth sleepiness scale) in diabetic patients with morbid obesity treated with exenatide.Material and methods: We studied consecutively 21 T2DM patients, all of them treated with metformin full dosage and insufficient metabolic control referred to our clinic for preoperative control of bariatric surgery. Twelve of ...